Sympathetic Electrical Stimulation Therapy for Chronic Pain

Similar documents
Name of Policy: Sympathetic Therapy and Bioelectrical Nerve Block or Electroanalgesic Nerve Block for the Treatment of Pain

MAGNETIC RESONANCE IMAGING (MRI) AND COMPUTED TOMOGRAPHY (CT) SCAN SITE OF CARE

H F 1 0 T H E R A P Y R E I M B U R S E M E N T R E F E R E N C E G U I D E

Genetic Testing for Inherited Conditions

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Bone Anchored Hearing Aids (BAHA) and Partially-Implantable Magnetic Bone Conduction Hearing Aids

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40

MP.094.MH Transcutaneous Electrical Nerve Stimulators

HF10 THERAPY 2018 Ambulatory Surgery Center Reimbursement and Coding Reference Guide

2 016 HF10 THERAPY HOSPITAL OUTPATIENT DEPARTMENT AND AMBULATORY SURGERY CENTER REIMBURSEMENT REFERENCE GUIDE

HYSTERECTOMY FOR BENIGN CONDITIONS

Nevro Reimbursement Support

2016 HF10 THERAPY REIMBURSEMENT REFERENCE GUIDE

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Clinical Policy: Cochlear Implant Replacements

Pharmacogenomic Testing for Warfarin Response (NCD 90.1)

Clinical Policy: Gastric Electrical Stimulation

Clinical Policy: Electric Tumor Treating Fields (Optune) Reference Number: CP.MP.145

Clinical Policy: Cochlear Implant Replacements Reference Number: CP.MP.14

Corporate Medical Policy

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction Reference Number: CP.MP.133

Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy

Highmark Medical Policy Bulletin

Physical Therapy and Occupational Therapy Initial Evaluation and Reevaluation Reimbursement Policy. Approved By

Electric Current Therapy (Iontophoresis) E/I ELECTRIC CURRENT THERAPY (IONTOPHORESIS) HS-237. Policy Number: HS-237. Original Effective Date: 1/9/2014

Ophthalmologic Policy. Vascular Endothelial Growth Factor (VEGF) Inhibitors

tens_(transcutaneous_electrical_nerve_stimulator) 7/ / / /2014 This policy is NOT effective until January 13, 2015

JOHNS HOPKINS HEALTHCARE

Ultrasound and Fluoroscopic Paravertebral Facet Joint Injections

Lumify. Lumify reimbursement guide {D DOCX / 1

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

Inspire Medical Systems. Physician Billing Guide

INFERTILITY SERVICES

Clinical Policy: Digital EEG Spike Analysis

HYSTERECTOMY FOR BENIGN CONDITIONS

Corporate Medical Policy

Clinical Policy: Digital Breast Tomosynthesis Reference Number: CP.MP.90

Clinical Policy: Implantable Miniature Telescope for Age Related Macular Degeneration Reference Number: CP.MP.517

Clinical Policy: Multiple Sleep Latency Testing

Clinical Policy: Essure Removal Reference Number: CP.MP.131

Peripheral Subcutaneous Field Stimulation

Peripheral Subcutaneous Field Stimulation

Coding and Payment Guide for Anesthesia Services. An essential coding, billing, and reimbursement resource for anesthesiology and pain management

Clinical Policy: DNA Analysis of Stool to Screen for Colorectal Cancer

Neurostimulator Devices and Supplies

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Medical Policy Vertebral Axial Decompression Section 8.0 Therapy Subsection 8.03 Rehabilitation. Description. Related Policies.

Empire BlueCross BlueShield Professional Reimbursement Policy

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207

URINE DRUG TESTING FOR SUBSTANCE ABUSE TREATMENT AND CHRONIC PAIN MANAGEMENT

PRESACRAL NEURECTOMY AND UTERINE NERVE ABLATION FOR PELVIC PAIN

Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Procedures 1 Performed by Emergency Medicine Physicians

Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Procedures Commonly Performed by Otolaryngologists

Premier Health Plan considers Negative Pressure Wound Therapy (NPWT) in the home setting medically necessary for the following indications:

Neurostimulators and Neuromuscular

See Policy CPT/HCPCS CODE section below for any prior authorization requirements

CODING SHEETS CHRONIC INTRACTABLE PAIN MANAGEMENT. Effective January 1, 2009 CODMAN 3000 NEUROMODULATION AND ONCOLOGY REIMBURSEMENT HOTLINE

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None

Clinical Policy: Total Artificial Heart Reference Number: CP.MP.127

Clinical Policy: Ambulatory Electroencephalography Reference Number: CP.MP.96

ICD-9-CM Diagnosis Code options

Coverage Guideline. BioniCare System (formerly the BIO-1000 System) DEFINITION COVERAGE CRITERIA MEDICAL BACKGROUND

FECAL OCCULT BLOOD TEST

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Product Name or Headline

2017 Hospital Coding and Payment Guide

ELECTROMYOGRAPHY (EMG) AND NERVE CONDUCTION STUDIES (NCS)

MedStar Health considers Cough Assist Devices medically necessary for the following indications:

Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Vascular Procedures 1

Vertebral Axial Decompression

Reimbursement Information for Diagnostic Musculoskeletal Ultrasound and Ultrasound-guided Procedures 1

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None

MOTORIZED SPINAL TRACTION

BRONCHIAL THERMOPLASTY

2018 Reimbursement Information for Mammography, CAD and Digital Breast Tomosynthesis 1

Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155

NON-SURGICAL ENDODONTICS

Medical Policy. MP Ingestible ph and Pressure Capsule

BlueCHiP for Medicare Not applicable

PHYSICIAN CODING AND PAYMENT GUIDE

RETIRED. Maximum Drug Dose Policy

Clinical Policy: Atezolizumab (Tecentriq) Reference Number: CP.PHAR.235 Effective Date: 06/16 Last Review Date: 05/17

Clinical Policy: Trigger Point Injections for Pain Management

Neuromuscular Electrical Stimulator (NMES) Corporate Medical Policy

Clinical Policy: Cardiac Biomarker Testing for Acute Myocardial Infarction Reference Number: CP.MP.156

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Clinical Policy: Phototherapy and Photochemotherapy for Dermatological Conditions Reference Number: CP.MP. 441

Clinical Policy: Homocysteine Testing Reference Number: CP.MP.121

Peripheral Subcutaneous Field Stimulation

Chiropractic Services

2017 Reimbursement Information for Mammography, CAD and Digital Breast Tomosynthesis 1

Clinical Policy: Fecal Calprotectin Assay Reference Number: CP.MP.135

Local Coverage Determination (LCD) for Chiropractic Services (L34816) (Posted for Notice)

PNEUMATIC COMPRESSION DEVICES IN THE HOME SETTING

Subject: Non-Invasive Electrical Bone Growth Stimulators (EBGS)

Local Coverage Article for Chiropractic Services (A47798) Contractor Information. Article Information. Contractor Name. Contractor Numbers

Transcription:

Sympathetic Electrical Stimulation Therapy for Chronic Pain Policy Number: 015M0076A Effective Date: April 01, 015 RETIRED 5/11/017 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION COVERAGE RATIONALE/CLINICAL CONSIDERATIONS BACKGROUND REGULATORY STATUS CLINICAL EVIDENCE APPLICABLE CODES REFERENCES POLICY HISTORY/REVISION INFORMATION 3 3 4 4 Spinal Cord Stimulator 014M000B Gastric Electrical Stimulation For Gastroparesis 013M001A Deep Brain Stimulation 01M0005A Pelvic Floor Electrical Stimulation for the Treatment of Urinary Incontinence 013M008A Neuromuscular Electrical Stimulation for Muscle Rehabilitation 015M0074A INSTRUCTIONS: Medical Policy assists in administering UCare benefits when making coverage determinations for members under our health benefit plans. When deciding coverage, all reviewers must first identify enrollee eligibility, federal and state legislation or regulatory guidance regarding benefit mandates, and the member specific Evidence of Coverage (EOC) document must be referenced prior to using the medical policies. In the event of a conflict, the enrollee's specific benefit document and federal and state legislation and regulatory guidance supersede this Medical Policy. In the absence of benefit mandates or regulatory guidance that govern the service, procedure or treatment, or when the member s EOC document is silent or not specific, medical policies help to clarify which healthcare services may or may not be covered. This Medical Policy is provided for informational purposes and does not constitute medical advice. In addition to medical policies, UCare also uses tools developed by third parties, such as the InterQual Guidelines, to assist us in administering health benefits. The InterQual Guidelines are intended to be used in connection with the independent professional medical judgment of a qualified health care provider and do not constitute the practice of medicine or medical advice. Other Policies and Coverage Determination Guidelines may also apply. UCare reserves the right, in its sole discretion, to modify its Policies and Guidelines as necessary and to provide benefits otherwise excluded by medical policies when necessitated by operational considerations. Page. 1 of 5

POLICY DESCRIPTION: This policy describes the use of electrical stimulation to the surface of the skin for the purpose of treating chronic pain. Treatment by sympathetic electrical stimulation therapy, also called Sympathetic Therapy System (STS), consists of placing electrodes on the surface of the patient s lower legs and feet or arms and hands and applying mild electrical current. The current treats the entire body. Other machines that use electric currents, such as TENS (transcutaneous electrical nerve stimulation) or interferential electrical stimulation, treat only parts of the body, or localized areas. Treatments typically begin as a series in an outpatient setting followed by treatments in the home. COVERAGE RATIONALE / CLINICAL CONSIDERATIONS: Sympathetic electrical stimulation for chronic pain is considered EXPERIMENTAL AND/OR INVESTIGATIONAL due to insufficient clinical evidence of safety and/or efficacy in published, peerreviewed medical literature. Therefore this health service is NOT MEDICALLY NECESSARY. Clinical Considerations: Clinical evidence does not support sympathetic electrical stimulation for treatment of chronic pain. There are no controlled studies that demonstrate the safety and efficacy of this treatment over other treatments for chronic pain. There is an expectation that the advantages, harms and alternatives of the procedure will be explained to the patient. BACKGROUND: Sympathetic electrical stimulation therapy, generally referred to as sympathetic therapy, is a type of electrical stimulation of the peripheral nerves of the sympathetic nervous system in an effort to "normalize" the autonomic nervous system and alleviate chronic pain. Unlike transcutaneous electrical nerve stimulation (TENS) or interferential electrical stimulation, sympathetic therapy is not designed to treat local pain, but is designed to induce a systemic effect on sympathetically induced pain. Sympathetic therapy uses 4 intersecting channels of various frequencies with bilateral electrode placement on the feet, legs, arms, and hands. Electrical current is induced with beat frequencies between 0 and 1000 Hz. Treatment may include daily 1-hour treatments in the physician s office, followed by home treatments. REGULATORY STATUS: Page. of 5

1. U.S. FOOD AND DRUG ADMINISTRATION (FDA): US Food and Drug Administration (FDA) clearance in 001 through a 510(k) process. The FDA-labeled indication is as follows: "Electrical stimulation delivered by the Dynatron STS and Dynatron STS Rx is indicated for providing symptomatic relief of chronic intractable pain and/or management of post-traumatic or post-surgical pain.". CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS): CMS Medicare does not have a National Coverage Determination (NCD) for sympathetic electrical stimulation for treatment of chronic pain. In the absence of an NCD, coverage decisions are left to the discretion of local Medicare carriers. No Local Coverage Determinations (LCD) for sympathetic electrical stimulation for treatment of chronic pain were identified. 3. MINNESOTA DEPARTMENT OF HUMAN SERVICES (DHS): Use of the Sympathetic Therapy System (e.g. Dynatron STS) is considered investigative for all indications. CLINICAL EVIDENCE: Only one clinical trial was identified in a search of published literature. SUMMARY: There is insufficient evidence from well-designed, randomized clinical trials regarding the impact of sympathetic therapy upon patient management and health outcomes for the treatment of pain or for any other indication. APPLICABLE CODES: The Current Procedural Terminology (CPT ) codes and HCPCS codes listed in this policy are for reference purposes only. Listing of a service or device code in this policy does not imply that the service described by this code is a covered or non-covered health service. The inclusion of a code does not imply any right to reimbursement or guarantee claims payment. Other medical policies and coverage determination guidelines may apply. Coding information generally will not be entered at the time of policy development. Coding information is provided by Claim Medical Management and added to the policy at a later date. HCPCS Codes E1399 Durable medical equipment, miscellaneous A9900 Miscellaneous DME supply, accessory, and/or service component of another HCPCS code ICD-9 Codes 337.0 Reflex sympathetic dystrophy, unspecified Page. 3 of 5

337.1 Reflex sympathetic dystrophy of the upper limb 337. Reflex sympathetic dystrophy of the lower limb 337.9 Reflex sympathetic dystrophy of other specified site 338.9 Other chronic pain 338.4 Chronic pain syndrome 356.9 Unspecified peripheral neuropathy ICD-10 Codes G60 G71 G89 G98 M60 M79 CPT Codes Hereditary and idiopathic neuropathy Primary disorders of muscles Pain, not elsewhere classified Other disorders of nervous system not elsewhere classified Myositis Other and unspecified soft tissue disorders, not elsewhere classified 64999 Unlisted procedure, nervous system CPT is a registered trademark of the American Medical Association. REFERENCES: 1. BlueShield of Idaho. The Regence Group. Policy No: 83.08. Sympathetic Electrical Stimulation Therapy. Last reviewed June 014. Available at: http://blue.regence.com/trgmedpol/dme/index.html Accessed February, 015.. Guido EH. Effects of sympathetic therapy on chronic pain in peripheral neuropathy subjects. AJPM 00;1:31-34. 3. Sacks SM, Ernst JA. Retrospective study of sympathetic therapy for pain attenuation in 197 patients. Unpublished. Available from the manufacturer, Dynatronics Corp. POLICY HISTORY: DATE ACTION/DESCRIPTION 0-16-015 New Policy number 015M0076A. Reviewed and approved by the Medical Policy Committee. 0/6/015 Reviewed and approved by the Quality Improvement Advisory and Credentialing Committee (QIACC). 03/01/015 Published to ucare.org Page. 4 of 5

07/01/015 Policy Update: Added applicable ICD-10 codes to the Coding Section. The list of codes may not be all-inclusive and does not denote coverage. Page. 5 of 5